Ignite Creation Date:
2024-07-17 @ 11:03 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06501924
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-15
First Post:
2024-07-08
Brief Title:
Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss
Sponsor:
Applied Biology Inc
Organization:
Applied Biology Inc
Study Overview
Official Title:
Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary objective of the study is to assess the safety and efficacy of DA-005 and DA-002 as a treatment for hair loss androgenetic alopecia
Detailed Description:
DA-005 is a botanical supplement with demonstrated HIF-1a inhibitory action The ingredients were tested in-vitro and have demonstrated the HIF-1a inhibitory effect This study aims to compare DA-005 to topical minoxidil in the treatment of hair loss also known as androgenetic alopecia
DA-002 is a topical alpha 1 agonist The ingredients were tested in-vitro and have demonstrated hair growth effects
This study aims to compare DA-005 and DA-002 to topical minoxidil in the treatment of hair loss also known as androgenetic alopecia
DA-002 is a topical alpha 1 agonist The ingredients were tested in-vitro and have demonstrated hair growth effects
This study aims to compare DA-005 and DA-002 to topical minoxidil in the treatment of hair loss also known as androgenetic alopecia
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None